The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios

Basu Sandip; Ostwal Vikas

首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios

【24h】

The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios

机译：转移性神经内分泌肿瘤中化疗-肽受体放射性核素联合治疗（chemo-PRRT）策略的案例：预测和展望可能的病例

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Nuclear Medicine and Molecular Imaging 》 |2016年第13期| 共3页
作者
Basu Sandip; Ostwal Vikas;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学 ;
关键词
Neuroendocrine tumor; Peptide receptor radionuclide therapy; Ga-68-DOTATATE; FDG-PET/CT; Chemotherapy; Lu-177-DOTATATE;

机译：神经内分泌肿瘤;肽受体放射性核素治疗;Ga-68-DOTATATE;FDG-PET / CT;化学疗法;Lu-177-DOTATATE;

相似文献

外文文献
中文文献
专利

1. The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios [J] . Basu Sandip, Ostwal Vikas European Journal of Nuclear Medicine and Molecular Imaging . 2016 ,第13期

机译：转移性神经内分泌肿瘤中化疗-肽受体放射性核素联合治疗（chemo-PRRT）策略的案例：预测和展望可能的病例
2. Safety and Efficacy of Combined Peptide Receptor Radionuclide Therapy and Liver Selective Internal Radiation Therapy in a Patient With Metastatic Neuroendocrine Tumor [J] . Maccauro Marco, Follacchio Giulia Anna, Spreafico Carlo, Clinical nuclear medicine . 2019 ,第4期

机译：组合肽受体放射性核素治疗和肝脏选择性内部放射治疗患者转移神经内分泌肿瘤的安全性和有效性
3. Performance of Lu-177-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics [J] . Thapa Pradeep, Ranade Rohit, Ostwal Vikas, Nuclear Medicine Communications . 2016 ,第10期

机译：基于Lu-177-DOTATATE的肽受体放射性核素治疗转移性胃肠内胰腺神经内分泌肿瘤的性能：与原发肿瘤部位，肿瘤增殖指数和双示踪成像特征相关的多参数反应评估
4. ~(213)Bi-DOTATOC receptor targeted alpha-radionuclide therapy induces remission in neuroendocrine tumors refractory to beta-radiation - a first in human study [C] . Giesel FL, Kratochwil C, Bruchertseifer F, 8th International Conference on Isotopes 2014 . 2014

机译：〜（213）Bi-DOTATOC受体靶向的α-放射性核素疗法可诱导难于β辐射的神经内分泌肿瘤缓解-这是人类研究中的首次
5. A combined X-ray CT-scintillation camera system for measuring radionuclide uptake in tumors. [D] . Tang, Hamilton Roger. 1998

机译：用于测量肿瘤中放射性核素吸收的组合式X射线CT闪烁摄像系统。
6. The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors [O] . Lisa Bodei, Jarosław B. Ćwikla, Mark Kidd, 2017

机译：肽受体放射性核素治疗在晚期/转移性胸神经内分泌肿瘤中的作用
7. Safety and Efficacy of Combined Peptide Receptor Radionuclide Therapy and Liver Selective Internal Radiation Therapy in a Patient With Metastatic Neuroendocrine Tumor [O] . Marco Maccauro, Giulia Anna Follacchio, Carlo Spreafico, 2019

机译：组合肽受体放射性核素治疗和肝脏选择性内部放射治疗患者转移神经内分泌肿瘤的安全性和有效性

The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios

著录项

相似文献

相关主题

期刊订阅